华兰生物 (002007)
Hualan Biological Engineering Inc.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 182745.67
- Circulating A-Shares(W): 157370.29
- Earnings Per Share(RMB): 0.4291
- Net Assets Per Share(RMB): 6.2228
- Operating Revenue(W RMB): 337888.64
- Total Profit(W RMB): 97241.42
- Net Profit Attributable to Parent(W RMB): 78442.30
- Net Profit Growth Rate(%): -15.07
- Weighted Return on Equity(%): 6.5500
- Operating Cash Flow Per Share(RMB): 0.2470
- Undistributed Profit Per Share(RMB): 3.9619
- Capital Reserve Per Share(RMB): 0.7795
2. Main Business
The main business covers:
- Blood products
- Vaccines
- R&D, production and sales of genetic engineering products
3. Company Basic Information
- Company Name: Hualan Biological Engineering, Inc.
- Listing Date: 2004-06-25
- Industry: Pharmaceutical Manufacturing
- Address: No.1 A Hualan Avenue, Xinxiang City, Henan Province
- Website: www.hualanbio.com
- Company Profile: The company is a foreign-invested joint-stock company established through the overall transformation of Hualan Biological Engineering Co., Ltd., approved by the Ministry of Foreign Trade and Economic Cooperation [2000] WJMZ No. 658 and the People's Government of Henan Province YGPZ [2000] No. 40.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Chongqing Shengkang Biotechnology Development Co., Ltd. | General Legal Person | 27443.87 | 17.44 |
| 2 | Hong Kong Kekang Co., Ltd. | General Legal Person | 23989.40 | 15.24 |
| 3 | Hong Kong Securities Clearing Company Ltd. | Northbound Funds | 2997.75 | 1.90 |
| 4 | Shouchuang Securities Co., Ltd. | Broker | 1988.02 | 1.26 |
| 5 | CSI 500 ETF | Fund | 1593.78 | 1.01 |
| 6 | China Merchants Guozheng Biopharmaceutical Index Securities Investment Fund (LOF) Class A | Fund | 1445.91 | 0.92 |
| 7 | Yongxin County Shengkang Xinkai Enterprise Management Consulting Center (Limited Partnership) | General Legal Person | 1350.20 | 0.86 |
| 8 | ChinaAMC Guozheng Vaccine and Biotechnology Index Initiation Securities Investment Fund Class A | Fund | 46.33 | 0.03 |
| 9 | Harvest CSI Vaccine and Biotechnology ETF | Fund | 45.18 | 0.03 |
| 10 | Penghua Guozheng Vaccine and Biotechnology ETF | Fund | 36.44 | 0.02 |
5. Concept Sectors
- Biological Vaccine
- Gene Concept
- Hepatitis Concept
- Innovative Drug
- Margin Trading & Securities Lending
- Heavily Held by Brokers
- High Dividend Stocks
- Spin-off Listing
- SME 100
- SZSE 300
- Technology 100
- SME 300
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information
